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Introduction
Multiple Sclerosis (MS) is an autoimmune,
neurodegenerative disease characterized by chronic
inflammation and demyelination of the brain and
spinal cord. This deterioration of the central nervous
system leads to a wide range of motor, cognitive, and
neuropsychiatric symptoms. Each patient varies in
symptom profile and disease course. However,
cognitive impairment has been found in roughly half of
all people with MS, regardless of MS subtype. This may
present as deficits in attention, information processing
speed, executive function, and visuospatial perception.
This impairment may interfere with basic and
instrumental activities of daily living, vocational status,
and social functioning; all of which may impact overall
quality of life. Likewise, depression can also alter
cognitive function, notably executive function. As MS
progresses, the development of depressive symptoms
in patients becomes more common. The objective of
the study was to determine if there was a correlation
between cognitive impairment and severity of
depression in patients with MS.

Methods
Participants with MS were administered tests for cognitive
function, including the Montreal Cognitive Assessment
(MoCA), a measure of cognitive impairment; the Symbol
Digit Modalities Test (SDMT), a measure of information
processing speed, attention, and working memory; and
the King‐Devick Test, which measures saccadic dysfunction
and attention. In addition, participants completed various
questionnaires including: the Perceived Stress Scale (PSS),
which assesses stress levels; the Center for
Epidemiological Studies Depression Scale (CES‐D), a
measure of depressive symptoms; the Perceived Deficits
Questionnaire (PDQ), a measure of cognitive dysfunction;
and the Fatigue Severity Scale (FSS), which evaluates
perceived fatigue and its impacts on daily functioning.
The research cohort was broken into 2 groups (cognitive
impairment or no cognitive impairment) based on SDMT
T‐scores, which were calculated using published norms
that account for age and education. The SDMT has been
well validated as a measure of cognitive decline in people
with MS. The groups were compared using ANOVA to
determine if they differed based on depression scores. A
correlation analysis also measured the relationship
between cognitive performance and depression
symptomology.

Comparison of Impaired and Non-Impaired
Groups on demographics
Impaired

Non-impaired

F

p

Sex

23 Females,
6 Males

21 Females,
4 Males

Age

43 ± 14.0

50 ± 12.4

3.57

0.06

Highest Level of
Education

14 ± 2.7

16 ± 2.6

10.86 0.002

Results – Self Report Measures
Comparison of Impaired and Non-Impaired
Groups on self-report measures
Impaired

Non-Impaired

F

p

PSS

18.45 ± 7.6

15.6 ± 6.7

2.00

0.16

CES-D

18.5 ± 11.2

13.8 ± 13.1

2.07

0.16

PDQ

32.8 ± 12.4

28.0 ± 16.1

1.53

0.22

FSS

39.4 ± 18.0

40.6 ± 16.1

0.06

0.80

Correlational Results
Correlation between SDMT score
and self-report measures
Impaired

Non-Impaired

PSS

r = -0.35
p = 0.08

r = 0.21
p = 0.32

CES-D

r = -0.08
p = 0.70

r = 0.07
p = 0.73

PDQ

r = 0.16
p = 0.42

r = 0.30
p = 0.15

FSS

r = 0.01
p = 0.10

r = 0.01
p = 0.64

With the Symbol Digit Modalities Test (SDMT), participants are given
90 seconds to correctly pair as many symbols with their corresponding
digit as they can.

Conclusion
When comparing patient demographics between the impaired and
non‐impaired groups, no significant differences were found between
the two groups with respect to age. However, the results indicated
that the two groups differed significantly in terms of education. The
impaired group had fewer years of education than the non‐impaired
group. This aligns with the theory of cognitive reserve, the concept
that certain factors, such as education, may be attenuate the effect
of disease burden on cognition.
The results showed that there was no significant differences
between the impaired and non‐impaired groups when comparing
self‐reported measures of depression symptomology. Likewise, the
results of the correlational studies demonstrated no significant
relationships between cognitive performance and self‐reported
measures of depression. However, this experiment was limited by
the small sample size and is currently an ongoing study. Thus,
further research and replication of this study with a larger sample
may be necessary before coming to a definitive conclusion.
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